Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Qiagen appoints staff for pharma business development team

Qiagen appoints staff for pharma business development team

26th April 2010

Qiagen has appointed Dr Pia Gargiulo and Richard Watts to key executive roles at its newly-formed pharma business development team.

Dr Gargiulo has been selected as a senior director of the new unit, with Mr Watts becoming a director, further expanding a team which includes former DxS staff members Peter Collins and Dr David Jackson.

Both newly-appointed executives have extensive experience in the healthcare sector, with Dr Gargiulo joining Qiagen from AstraZeneca, while Mr Watts’ former employers include Bio-Rad and Invitrogen.

The science company’s pharma business development team has been formed following last year’s takeover of DxS and is intended to oversee drug-diagnostic co-development programmes with pharmaceutical partners.

Mr Collins, vice-president and leader of the new team, said Dr Gargiulo and Mr Watts “will play a key part in further strengthening Qiagen’s position as the pharmaceutical industry’s companion diagnostic partner of choice”.

According to the company’s most recent financial report, Qiagen enjoyed a strong fourth quarter of 2009, exceeding its performance from the corresponding period of 2008 by 22 per cent.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.